Moreover, they are only effective for patients with mild-to-moderate AD [8], and sometimes have a different therapeutic effect in treating different phenotypes of apolipoprotein E-genotyped patients, with the apolipoprotein E gene a well-known gene that influences Alzheimer’s risk [9]. Here, APOE is linked to Alzheimer disease.